Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

SSP+ - Health Canada Drug Approval Details

Approvals/Health Canada/SSP+

Authorized

STANDARD

SSP+

maco pharma🇨🇦 Health Canada

Approval Date: Jul 4, 2025
Approval ID: 37cd82d0f4c0f88d
Company: maco pharma
Type: Standard

Approval Details

Approval Id: 37cd82d0f4c0f88d
Drug Approval Canada Name: SSP+
Product Name: SSP+
Status: Marketed
Status Date: 2021-11-05
Original Market Date: 2021-11-05
Din: 02492067
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intravenous
Schedule: Ethical
Ahfs: 96:00.00
Atc Original: V07AC BLOOD TRANSFUSION, AUXILIARY PRODUCTS
Atc Name: v 07 ac
Aig Number: 0761850001
Company Name: maco pharma
Company Address: Rue Lorthiois, Mouvaux, Nord-Pas-De-Calais, France, 59420

Active Ingredients

MAGNESIUM CHLORIDE

0.3 G / L

SODIUM CHLORIDE

4.05 G / L

DISODIUM PHOSPHATE

3.05 G / L

SODIUM ACETATE

4.42 G / L

SODIUM CITRATE

3.18 G / L

SODIUM PHOSPHATE MONOBASIC

1.05 G / L

POTASSIUM CHLORIDE

0.37 G / L

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

37cd82d0f4c0f88d

Type

Standard

Back to Health Canada Approvals